Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Jack Henneman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Alafair Biosciences appoints John Joyoprayitno as new President and CEO News provided by Share this article AUSTIN , Texas, March 2, 2021 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company and developer of VersaWrap ®, announced today that John Joyoprayitno has been appointed as its new Chief Executive Officer. "John is a proven leader and has the vision to take Alafair to the next level," said Jack Henneman, Alafair Board Member. "He has done an outstanding job as President and COO, taking Alafair from a pre-commercial company to a growing medical device ...